Class of Alzheimer's drug presents unique challenge for patients with cardiovascular disease
A new Viewpoint article published in the Journal of the American Medical Association (JAMA), titled " Use of Lecanemab for Patients with Cardiovascular Disease—The Challenge of Uncertainty," advocates for additional research ...
Mar 18, 2024
0
1